(Q34349522)

English

Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

Alzheimer's disease

0 references

mild cognitive impairment

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

Lars-Olof Wahlund

5

object named as

Lars-Olof Wahlund

0 references

Daniel Ferreira

object named as

Daniel Ferreira

1

0 references

object named as

Eric Westman

4

0 references

Lilisbeth Perestelo-Pérez

3

object named as

Lilisbeth Perestelo-Pérez

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Pedro Serrano-Aguilar

7

object named as

Pedro Serrano-Aguilar

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Amado Rivero-Santana

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Antonio Sarría

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

16 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Frontiers in Aging Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

287

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

CSF biomarkers for Alzheimer's disease: current utility and potential future use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Tau and p-tau as CSF biomarkers in dementia: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

CSF Biomarkers for Alzheimer's Disease Diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Meta-DiSc: a software for meta-analysis of test accuracy data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Neuropathology of older persons without cognitive impairment from two community-based studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Mild cognitive impairment as a diagnostic entity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Current concepts in mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Multicenter clinicopathological correlation in dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Meta-analysis in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Clinically diagnosed Alzheimer disease: neuropathologic findings in 650 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

6 July 2018

Revised criteria for mild cognitive impairment: validation within a longitudinal population study.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

CSF biomarker levels in early and late onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Combination of hippocampal volume and cerebrospinal fluid biomarkers improves predictive value in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Supporting evidence for using biomarkers in the diagnosis of MCI due to AD.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Cerebrospinal fluid amyloid beta42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Cerebrospinal fluid markers for prediction of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

[Biomarkers in the cerebrospinal fluid of patients with mild cognitive impairment: a meta-analysis of their predictive capacity for the diagnosis of Alzheimer's disease].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

27 October 2018

Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199277

27 October 2018

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00287

21 January 2018

Classification criteria for mild cognitive impairment: a population-based validation study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detecting and describing heterogeneity in meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers of Alzheimer's disease in the cerebrospinal fluid of Spanish patients with mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3389/FNAGI.2014.00287

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34349522&oldid=1746338882"